A significant advance in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This essential tumor suppressor protein is frequently disabled in many kinds of tumors, resulting https://bookmarkboom.com/story21909563/nanobodies-restore-the-p53-protein-new-potential-hope-for-tumor-management